| Title : FAAH and MAGL inhibition: Evolving approaches to treating substance use disorders - Maddox_2025_Neurotherapeutics__e00814 |
| Author(s) : Maddox CJ , Lee FS , Rajadhyaksha AM , Martinez-Rivera A |
| Ref : Neurotherapeutics , :e00814 , 2025 |
| Abstract : |
| PubMedSearch : Maddox_2025_Neurotherapeutics__e00814 |
| PubMedID: 41350173 |
| Title : FAAH and MAGL inhibition: Evolving approaches to treating substance use disorders - Maddox_2025_Neurotherapeutics__e00814 |
| Author(s) : Maddox CJ , Lee FS , Rajadhyaksha AM , Martinez-Rivera A |
| Ref : Neurotherapeutics , :e00814 , 2025 |
| Abstract : |
| PubMedSearch : Maddox_2025_Neurotherapeutics__e00814 |
| PubMedID: 41350173 |
| Title : FAAH and MAGL inhibition: Evolving approaches to treating substance use disorders - Maddox_2025_Neurotherapeutics__e00814 |
| Author(s) : Maddox CJ , Lee FS , Rajadhyaksha AM , Martinez-Rivera A |
| Ref : Neurotherapeutics , :e00814 , 2025 |
| Abstract : |
| PubMedSearch : Maddox_2025_Neurotherapeutics__e00814 |
| PubMedID: 41350173 |